When the Regulator's Letter Arrives
Imagine you are the founder of a fast-growing SaaS startup in Singapore. One morning, a letter arrives from the Accounting and Corporate Regulatory Authority (ACRA) requesting financial records for the past three years. Your mind immediately jumps past office logistics to a far more uncomfortable question: if this investigation escalates, am I personally liable for the defence costs?
For directors and officers of Singapore companies, regulatory enforcement is not merely a corporate inconvenience. Without adequate protection, legal fees, settlement amounts, and regulatory penalties can pierce the corporate veil and place personal assets—your home, savings, and investments—directly at risk.
Singapore's Regulatory Frontlines: ACRA, MAS and MOM
Singapore's compliance landscape is rigorous. Three regulators generate the majority of Directors and Officers (D&O) claims triggers for local companies:
- ACRA: Investigations into financial reporting discrepancies, late filings, or breaches of the Companies Act.
- MAS (Monetary Authority of Singapore): Anti-money laundering (AML) and countering the financing of terrorism (CFT) queries, particularly for fintech and payment firms.
- MOM (Ministry of Manpower): Foreign-worker compliance audits, salary disputes, and workplace safety and health (WSH) investigations.
A D&O policy responds by covering defence costs, civil fines (where insurable by law), and settlement amounts arising from alleged wrongful acts committed in your capacity as a director or officer.
Side-A, Side-B and Side-C: Coverage Architecture
D&O policies are structured in three distinct sides. For small and medium-sized enterprises (SMEs), understanding which side your board carries is essential:
| Coverage Side | Who It Protects | Typical Applicant |
|---|---|---|
| Side-A | Individual directors when the company cannot indemnify them | Privately held SMEs and startups |
| Side-B | The company, by reimbursing director indemnification | Well-capitalised private firms |
| Side-C | The corporate entity for securities claims | Listed companies or pre-IPO firms |
For a privately held startup, Side-A coverage is critical. It ensures that if the company is insolvent or legally prohibited from paying your legal fees, your personal assets remain shielded throughout the investigation.
The Coverage Gaps Most Boards Miss
Even with a policy in force, directors can find themselves exposed. Watch for these three gaps:
- Fraud exclusions: Most policies exclude fraudulent or deliberately dishonest acts. However, the insurer typically bears the burden of proving fraud before denying cover.
- Dishonesty carve-backs: Some Side-A policies contain carve-backs that allow the insurer to recoup costs if a director is later found liable for dishonesty. This creates significant uncertainty during prolonged investigations.
- Non-resonant allocation: When claims involve both insured directors and uninsured parties (such as the company itself in a regulatory matter), the policy must contain a clear allocation clause. Without it, disputes over who pays what percentage of defence costs can delay funding for months.
Max-Shield Insight: The most commonly overlooked detail in Singapore D&O programmes is the absence of a non-resonant allocation clause. In a regulatory investigation involving both directors and the corporate entity, this clause determines whether defence costs are split fairly—or whether directors must fund their own legal representation until the matter concludes.
When the Letter Lands: The Claims Process
Receiving a regulatory notice triggers specific obligations under your D&O policy. Follow this sequence:
- Notify promptly: Most policies require notification as soon as you become aware of a circumstance that could reasonably lead to a claim. A formal regulatory letter almost always meets this threshold.
- Co-operate with the insurer: Provide all requested documents and maintain detailed records of every interaction with the regulator.
- Understand cost mechanics: Defence costs are typically advanced by the insurer as incurred, meaning you do not pay upfront and wait for reimbursement. However, if the policy contains a reimbursement-only structure, you must fund the initial legal fees yourself and claim them back later—a significant cash-flow burden for SMEs.
A Board-Level Framework for Annual D&O Reviews
D&O limits should not remain static. We recommend reviewing coverage at three inflection points:
- Pre-Series A funding: Ensure Side-A limits match at least 12 to 24 months of estimated defence costs.
- Post-fundraising: Investor due diligence often mandates higher limits. Match the limit to a meaningful percentage of funds raised.
- Pre-IPO or major acquisition: Introduce Side-C coverage and review regulatory tail provisions carefully.
Your Action Plan This Week
- Request a copy of your current D&O policy wording and locate the fraud exclusion and allocation clauses.
- Confirm whether your policy advances or merely reimburses defence costs.
- Calendar an annual D&O review 60 days before your policy renewal.
- Benchmark your limits against your last funding round or revenue milestone.
Conclusion
Regulatory investigations in Singapore are increasingly precise and unforgiving. A well-structured D&O policy is not a luxury—it is a fundamental layer of your personal risk architecture. By understanding how coverage responds, where gaps hide, and when to review limits, you protect both your board and your balance sheet.
Speak with our team about including a D&O review in your next annual risk review, or explore our corporate and business insurance solutions to build a comprehensive protection framework.
